DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 534 shares of DocuSign stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the completion of the sale, the director now owns 8,270 shares of the company’s stock, valued at approximately $722,880.70. This trade represents a 6.07 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.
DocuSign Stock Performance
Shares of DOCU opened at $85.61 on Thursday. DocuSign, Inc. has a 1 year low of $48.70 and a 1 year high of $107.86. The company has a market cap of $17.30 billion, a price-to-earnings ratio of 17.65, a price-to-earnings-growth ratio of 6.94 and a beta of 1.02. The firm has a fifty day moving average of $87.67 and a 200-day moving average of $79.91.
DocuSign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings data on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.02. The business had revenue of $776.25 million during the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.76 earnings per share. Analysts predict that DocuSign, Inc. will post 1.17 EPS for the current year.
Institutional Investors Weigh In On DocuSign
Analyst Upgrades and Downgrades
DOCU has been the subject of a number of research analyst reports. Citigroup lifted their price target on shares of DocuSign from $113.00 to $115.00 and gave the stock a “buy” rating in a research note on Friday, March 14th. Piper Sandler boosted their target price on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. upgraded shares of DocuSign from an “underweight” rating to a “neutral” rating and boosted their target price for the company from $70.00 to $75.00 in a research note on Monday, March 10th. Wedbush reiterated a “neutral” rating and set a $100.00 target price on shares of DocuSign in a research note on Friday, March 14th. Finally, Jefferies Financial Group boosted their target price on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $95.00.
Check Out Our Latest Research Report on DOCU
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than DocuSign
- How to Find Undervalued Stocks
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Investing in Construction Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- What is Insider Trading? What You Can Learn from Insider Trading
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.